𝔖 Bobbio Scriptorium

✦ LIBER ✦

Vaso-active therapy can improve 6-min walk distance in patients with pulmonary hypertension and fibrotic interstitial lung disease

✍ Scribed by Omar A. Minai; D. Sahoo; J.T. Chapman; A.C. Mehta

Book ID: 116872175
Publisher: Elsevier Science
Year: 2008
Tongue: English
Weight: 258 KB
Volume: 102
Category: Article
ISSN: 0954-6111
DOI: 10.1016/j.rmed.2008.02.002

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Bosentan therapy in patients with pulmon

Bosentan therapy in patients with pulmonary arterial hypertension: The relationship between improvements in 6 minute walk distance and quality of life

✍ Geoff STRANGE; Anne M. KEOGH; Trevor J. WILLIAMS; John WLODARCZYK; Keith D. MCNE 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 119 KB

[American Thoracic Society American Thor

[American Thoracic Society American Thoracic Society 2010 International Conference, May 14-19, 2010 • New Orleans - ()] D48. INTERSTITIAL LUNG DISEASE: PATHOBIOLOGY, BIOMARKERS AND TREATMENT - 6 Minute Walk Distance (6MWD) And Forced Vital Capacity (FVC) In Patients With Idiopathic Pulmonary Fibrosis (IPF): Similar Pattern Of Pirfenidone Response

✍ Valeyre, Dominique; Albera, Carlo; Du Bois, Roland M.; Bradford, Williamson Z.; 📂 Article 📅 2010 🏛 American Thoracic Society ⚖ 28 KB